MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease

    K. Tosefsky, Y. Wang, A. Kuan, V. Ngo, C. Agu, D. Liang, L. Liu, O. Geiger, S. Keymanesh, M. Sacheli, E. Gerson, S. Cresswell (Vancouver, Canada)

    Objective: ​​​To assess the feasibility of combining Mediterranean and ketogenic dietary principles in persons with Parkinson’s disease (PwP). Background: Dietary interventions have been proposed as…
  • 2024 International Congress

    Characteristics of Parkinson’s disease and associated healthcare resource utilization trends in a US all-payer health administrative claims database

    W. Zhang, S. Shuvo, A. Gabriel, A. Yaldo, G. Agreda, C. Goetzsche, T. Machewitz, M. Nadimi, J. Lott (Whippany, USA)

    Objective: To describe sociodemographic characteristics and healthcare resource utilization (HRU) among Parkinson’s disease (PD) patients across US health insurance plans. Background: PD affects nearly 1…
  • 2024 International Congress

    Clinical profile of early-onset Parkinson’s disease

    S. Peña Martinez, R. Ayala Minero, R. Amaya, A. Medina Escobar, P. Salles (San Salvador, El Salvador)

    Objective: Describe motor and non-motor symptoms, complications and treatment in patients with early-onset Parkinson's disease (EOPD) Background: PD usually affecting people over age 60, clinically…
  • 2024 International Congress

    Prevalence of Helicobacter Pylori Infection Among Nepalese Parkinson’s Disease Patients and their Clinical Manifestations

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, R. Hamal, A. Jha, R. Pathak (Kathmandu, Nepal)

    Objective: To know the prevalence of Helicobacter Pylori infection among Nepalese Parkinson´s Disease patients and understand their clinical characteristics Background: Helicobacter pylori (HP) is prevalent…
  • 2024 International Congress

    Unveiling Parkinson’s Disease Risk Factors in the European Population-Based HeBA Cohort

    A. Garrido, C. Horlings, K. Rege, S. Schade, S. Ghosh, P. Mahlknecht, R. Rawal, T. Marques, D. Pilco, C. Gomes, C. Pauly, F. Farfan, D. Mcintyre, K. Seppi, MJ. Marti, C. Trenkwalder, W. Poewe, E. Tolosa, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

    Objective: Describe the frequency of Parkinson’s disease (PD) risk factors in a European population-based study and analyze the predictive value of online survey single questions…
  • 2024 International Congress

    A Network Analysis shows How Impulsive-Compulsive Behaviors correlates with Levodopa-Induced Dyskinesia

    B. Veiga, C. Silva, S. Silva, R. Saba, H. Ferraz, V. Borges (São Paulo, Brazil)

    Objective: To study Impulsive Compulsive Behaviors (ICBs) and Levodopa-Induced Dyskinesias (LIDs) in Young Onset Parkinson's disease (YOPD) patients. Background: Parkinson's disease (PD) is a neurodegenerative…
  • 2024 International Congress

    Non-Motor Symptoms and Comorbidities in a Cohort of Puerto Rican Parkinson’s Disease: Do They Affect Severity and Progression?

    C. Serrano, K. Palermo, M. Morales, V. Wojna (San Juan, Puerto Rico)

    Objective: To describe for the first time the frequency of non-motor symptoms (NMS) and comorbidities in a group of idiopathic Parkinson disease (IPD) patients at…
  • 2024 International Congress

    Exploring the Influence of Sleep Disorders on Speech Intensity in Individual’s with Parkinson’s Disease

    A. Senthinathan, K. Bean (Buffalo, USA)

    Objective: This study aimed to examine the impact that sleep disorders and disturbances have on speech intensity in individuals with Parkinson’s disease (PD). Background: PD…
  • 2024 International Congress

    Pharmacokinetic Intersections in Geriatric Neuropharmacology: A Parkinson’s Disease Case Study with Concomitant Refractory Major Depressive Disorder

    D. Nolasco, L. Schmidt, B. Carr (Gainesville, USA)

    Objective: This investigation delineates the pharmacokinetic intricacies encountered in the therapeutic management of a geriatric patient with Parkinson’s Disease (PD) concomitantly suffering from refractory Major…
  • 2024 International Congress

    Young-onset Parkinson’s disease in a female with pathogenic deletion of the PRRT2 gene

    M. Chen, M. Christie (Houston, USA)

    Objective: To report a novel case of young-onset Parksinon’s disease (YOPD) associated with a pathogenic deletion of the proline-rich transmembrane protein 2 gene (PRRT2). Background:…
  • « Previous Page
  • 1
  • …
  • 231
  • 232
  • 233
  • 234
  • 235
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley